the U.S. Food and Drug Administration’s (FDA) decision to “withhold agency data regarding the sale of antibiotics for use in food animals” is unlawful, according to a lawsuit filed by the Government Accountability Project (GAP) Dec. 5.
Vitiva has opened a US office in Kentucky to better serve the North American market, and has appointed Connie Sandusky as vice president, sales and marketing for North America.
Eight ingredients have won EU health claims that can be used to back messaging around metabolic syndrome – although the take-up to date has been lacklustre, says Euromonitor analyst, Diana Cowland.
Bunge Limited today announced it has entered into a definitive agreement with Yara International ASA under which Yara will acquire Bunge’s Brazilian fertilizer business.
CP Kelco has been audited and has met the requirements for Food Safety System Certification (FSSC 22000) for all nine manufacturing facilities located across the globe.
Palsgaard is expecting to grow further in the Asia Pacific region. The company is on track to open a new factory in neighbouring Johor Bahru, Malaysia by mid-2013.
Naturex announces an equity investment by Groupe Caravelle, a diversified French industrial group with holdings in the pharmaceutical, industrial bodywork, mechanics and hotel sectors.
The US Food and Drug Administration (FDA) has amended the food additive regulations to provide the safe use of an antimicrobial agent after a petition from Ecolab.
The European leader in pulses and grains opens a dedicated production facility for pulses, investing more than $2.5 million in its core business in the next three years.
IFFO, the Marine Ingredients Organisation has launched an informative video about Omega-3's, nature's own health products entitled 'Marine Omega-3 - The Healthiest Fats'.
The potential of using organic catalysts to improve nitrification processes is promising due to the oxygen demand required for oxidation of ammonia to nitrate.
The U.S. International Trade Commission (“ITC”) issued a notice terminating the patent infringement investigation brought by Kaneka Corporation with a finding of no violation by Zhejiang Medicine Co., Ltd. (“ZMC”).
